DE1667898A1 - Mittel und Verfahren zur Glaukombehandlung - Google Patents

Mittel und Verfahren zur Glaukombehandlung

Info

Publication number
DE1667898A1
DE1667898A1 DE19681667898 DE1667898A DE1667898A1 DE 1667898 A1 DE1667898 A1 DE 1667898A1 DE 19681667898 DE19681667898 DE 19681667898 DE 1667898 A DE1667898 A DE 1667898A DE 1667898 A1 DE1667898 A1 DE 1667898A1
Authority
DE
Germany
Prior art keywords
epoxy
glaucoma
methods
dihydro
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681667898
Other languages
German (de)
English (en)
Inventor
Stone Clement Addison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1667898A1 publication Critical patent/DE1667898A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19681667898 1967-03-16 1968-03-15 Mittel und Verfahren zur Glaukombehandlung Pending DE1667898A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62354067A 1967-03-16 1967-03-16

Publications (1)

Publication Number Publication Date
DE1667898A1 true DE1667898A1 (de) 1971-07-22

Family

ID=24498471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681667898 Pending DE1667898A1 (de) 1967-03-16 1968-03-15 Mittel und Verfahren zur Glaukombehandlung

Country Status (8)

Country Link
US (1) US3467756A (fr)
BE (1) BE712259A (fr)
DE (1) DE1667898A1 (fr)
FR (1) FR7841M (fr)
GB (1) GB1174882A (fr)
IE (1) IE31971B1 (fr)
IL (1) IL29570A (fr)
NL (1) NL6802823A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716952A (en) * 1992-03-18 1998-02-10 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
US6077839A (en) 1992-03-19 2000-06-20 Allergan Sales, Inc. Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
WO1995034302A2 (fr) * 1994-06-16 1995-12-21 Allergan Procede utile pour reduire la pression intraoculaire dans l'×il mammalien a l'aide de composes chelatant le calcium
US6350780B1 (en) 1995-07-28 2002-02-26 Allergan Sales, Inc. Methods and compositions for drug delivery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264342A (en) * 1963-05-24 1966-08-02 Geigy Chem Corp Derivatives of 5h-dibenzo[a, d] cycloheptene
US3336340A (en) * 1963-11-29 1967-08-15 Rohm & Haas Benzopyrans and process for the preparation thereof

Also Published As

Publication number Publication date
IL29570A (en) 1971-07-28
GB1174882A (en) 1969-12-17
NL6802823A (fr) 1968-09-17
BE712259A (fr) 1968-09-16
FR7841M (fr) 1970-05-25
US3467756A (en) 1969-09-16
IE31971B1 (en) 1973-03-07
IE31971L (en) 1968-09-16

Similar Documents

Publication Publication Date Title
DE69435095T2 (de) Neue Behandlungsmethoden durch Verwendung von Phenethylaminderivaten
DE60001223T2 (de) Tris enthaltende propofol-formulierung
DE1792410B2 (de) Arzneimittelzubereitung zur intravenösen Injektion
EP0125634B1 (fr) Utilisation d'une substance sécrétolytique pour l'obtention d'un agent contre le ronflement et pour combattre le phénomène de ronflement
DE1902227A1 (de) Arzneimittel zur psychotherapeutischen Anwendung und Verfahren zu seiner Herstellung
EP0002495B1 (fr) Composition à utiliser en thérapie cytostatique
DE19938825A1 (de) Wirkstoffkombination mit Clonidin
EP0214620B1 (fr) Forme d'application transdermique de diltiazem
DE2918799A1 (de) Ophthalmische loesung
DE3317692A1 (de) Verwendung von metkephamid oder eines pharmazeutisch unbedenklichen salzes hiervon als analgetikum bei traechtigen weiblichen tieren und insbesondere bei schwangeren frauen
DE3317530A1 (de) Antischnarchmittel
DE60132325T2 (de) Ophthalmische lösung
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
DE69229688T4 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
DE69937692T2 (de) Aetherische oele zur behandlung der hemicrania
DE1915798B2 (de) Antacidum-praeparat in form einer waessrigen suspension
DE1667898A1 (de) Mittel und Verfahren zur Glaukombehandlung
DE3411104A1 (de) Zusammensetzung zur verringerung des augeninnendruckes
DE2427732A1 (de) Mittel zum anaesthesieren von saeugetieren
DE69922252T2 (de) Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
DE69730045T2 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE2163054A1 (de) Lokalanaesthetisches mittel
EP0529499A1 (fr) Compositions à utilisation topique pour l'application au nez ou aux yeux à base d'antagonistes de bradykinine
DE60304458T2 (de) Verwendung eines l-ascorbinsäuresalzes zur herstellung einer pharmazeutischen zusammensetzung für die ophthalmische topische anwendung zur verbesserung des l-ascorbinsäurespiegels im auge
DE2723936A1 (de) Ophthalmische loesung fuer die glaucom-behandlung